| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 5Developing evidence | 100.0% (5/5) | 40.0% (2/5) | -6.3% | -3.0% | -15.8% |
| 20D | 4Small sample | 100.0% (4/4) | 50.0% (2/4) | +0.2% | +4.8% | -6.3% |
| 60D | 4Small sample | 100.0% (4/4) | 100.0% (4/4) | +58.3% | +64.1% | +51.8% |
| 120D | 4Small sample | 100.0% (4/4) | 100.0% (4/4) | +17.9% | +17.9% | +5.3% |
COMPANY RESEARCH
SciBase Holding AB (publ)
SCIB.ST · Sweden · Healthcare · Medical Devices
INSIDER SIGNAL
Insider activity score：71.3 / 100
4 insiders · 6 purchase events · €51k net purchases
Europe #49 · Sweden #6
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
Cluster+35.0 / 35
How many distinct insiders bought in the cluster
Purchase size+17.6 / 25
Purchase value relative to company size and liquidity
Role+20.0 / 20
The seniority and relevance of participating insiders
Recency+8.7 / 10
How recently the purchases occurred
Conviction+10.0 / 10
How clearly buying stands out from other activity
What is holding the score back?
- ✓ Broad buyer cluster · 4+ distinct filers
- ✓ Strong insider role · ceo/chair involved
- ✓ Recent activity · latest purchase 2026-10-15
The role contribution uses the inverted role input of the current European model.
Buying concentration
57%
Largest buyer：jesper hoeiland · 998k SEK
Gross qualified purchase transaction-line value：1.75m SEK
The headline € total is net buying for the screen; this module uses gross qualified purchase transaction-line values in the filing currency, so the amounts can differ. The current 15-day buyer-breadth input counts distinct buyers; value concentration is disclosed separately here.
This is a ranking under the current European screening rules—not a probability of gain, return forecast, or buy recommendation.
Key purchase quotes (filing currency)
| Filer | Price per unit | Trade date |
|---|---|---|
| Robert Molander | 15 SEK | Oct 15, 2026 |
| jesper hoeiland | 15 SEK | Oct 14, 2026 |
| jesper hoeiland | 15 SEK | Sep 29, 2026 |
Model details
Cluster breakdown (does not change the score)
- 15-day buyer breadth (count)
- 4 distinct reported filers
- Peak time window
- 2026-09-30 to 2026-10-15
- Current breadth input
- 1.000 (capped at 4+ buyers)
- Buyer independence
- Not yet measured; related-party fields are not cross-market comparable
What the filings show
- 🟢 Recent eligible purchase
Robert Molander · 467k SEK · Price 15 SEK · Oct 15, 2026 - 🟢 Eligible purchase
jesper hoeiland · 620k SEK · Price 15 SEK · Oct 14, 2026 - 🟢 Large eligible purchase
jesper hoeiland · 378k SEK · Price 15 SEK · Sep 29, 2026 - 🟡 4 remaining qualified transaction line(s) across 4 disclosure(s)
Insider vs stock price
5 purchase day(s), 7 purchase line(s) in the 180-day window.
Daily close (SEK)Day with an insider purchaseTwo or more insiders the same day
Markers sit on the closing price of the transaction day. They show when insiders traded, not the price they paid or received. "Since" compares that day's close with the last close shown; it is what happened at this company, not a forecast.
If you had followed the purchase
Each row starts on the first close on or after the day a purchase was made public, the earliest a reader could have acted, and ends on the last close shown above.
| Made public | Insiders | In this stock, now | In the median peer stock, now | Difference |
|---|---|---|---|---|
| 2026-09-30 | 1 | 890 −11.0% | 1,003 +0.3% | −113 −11.3 pts |
| 2026-10-01 | 2 | 950 −5.0% | 1,017 +1.7% | −67 −6.7 pts |
| 2026-10-05 | 1 | 956 −4.4% | 1,017 +1.7% | −61 −6.1 pts |
| 2026-10-15 | 2 | 976 −2.4% | 1,011 +1.1% | −35 −3.5 pts |
0 of 4 disclosure day(s) ended ahead of the median peer stock.
Close to close, before costs, taxes, dividends and currency moves. The peer is the median of the other stocks on the same exchange for which this site holds prices (33 here), not an index. This is what happened, not a forecast: across all purchases on this site the typical gap is close to zero.
Insider timeline
3 insiders bought within 7 days, 29 Sep to 5 Oct: 2 CEO / chair, 1 CFO. 1 of them bought again later. 1 more bought afterwards. The share closed at 15.55 on the first of those days and at 14.15 most recently (−9.0%). That week 183 companies across Europe disclosed insider purchases, an ordinary week (13 of the last 26).
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
▮Purple band: several insiders bought within 15 days
The band marks the stretch with the most different buyers: at most 15 days long and at least two people. Here it is 29 Sep – 5 Oct, with 3 insiders. Only the strongest stretch is marked. Several people deciding the same thing is harder to explain by one person's private reasons, but insiders often buy together just after a closed period ends, so compare it with the grey weekly bars.
Blue line: this share's price, −64.5% over these six months
The closing price of each day, from 39.90 on 2026-04-21 to 14.15 on 2026-10-16. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, −9.2%
Taken from the 457 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −64.5%, the typical one −9.2%, 55.3 points behind. It is not an index and not a comparison within one industry.
▂Grey bars: companies across Europe disclosing purchases each week
A taller bar is a week in which more companies disclosed insider purchases. The purple bar is the week of the band above: 183 companies, number 13 of the last 26 weeks. If that week was a peak anyway, buying together is less special than it looks.
This company: insiders buying per month, last 12 months
Nov
Dec
4Jan
5Feb
Mar
Apr
May
Jun
Jul
Aug
3Sep
3Oct
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since | Earlier purchases |
|---|---|---|---|---|---|---|---|
| jesper hoeiland | CEO / chair | 2 | — | 998.0k SEK | 2026-09-29 | −9.0% | fewer than 5 completed |
| Pia Henriksson Renaudin | CEO / chair | 2 | — | 162.0k SEK | 2026-09-29 | −9.0% | fewer than 5 completed |
| Michael Colérus | CFO | 1 | — | 123.8k SEK | 2026-09-30 | −11.0% | fewer than 5 completed |
| Robert Molander | Board member | 1 | — | 466.9k SEK | 2026-10-15 | −2.4% | fewer than 5 completed |
Why this score? · Model details
Priority = 100 × Σ(fixed weight × 0–1 rule-based input)
| Factor | Weight | This company input | Point contribution |
|---|---|---|---|
| 15-day buyer breadth (count) | 35% | 1.000 | 35.0 |
| Qualified-buy size | 25% | 0.703 | 17.6 |
| Role informativeness (inverted) | 20% | 0.000 | 0.0 |
| Recency | 10% | 0.871 | 8.7 |
| Buy/sell conviction | 10% | 1.000 | 10.0 |
This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.
BULL VS BEAR
Two readings of this buying
The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.
Since 2026-10-13: new on the bear side: loss-making; no longer on the bear side: thinly traded. All bull and bear lists, and what followed each line in the past →
Where the evidence comes from
The two kinds of evidence disagree: the purchases themselves carry bull lines (large purchases, senior executive buying, bought in the last two weeks), while share price and trading argue against (price down over six months, price trails its sector); company results argue against (loss-making).
- The insider purchases themselvesBulllarge purchases, senior executive buying, bought in the last two weeks Bearusual level for this company4 checked, under the threshold · 2 missing
- Share price and tradingBearprice down over six months, price trails its sector
- Short sellers1 checked, under the threshold
- Company resultsBearloss-making1 missing
- Company actionsBearsubscription to new shares
Bull case · the buying is informative
- Net purchases of €51k equal 0.28% of the company's market value (€18.4M): large for the size of the business.
- The buyers include the CEO or chair, who sees more of the business than most filers. This site's score gives little or no credit for that: in its backtests purchases by senior executives did no better than other insiders' purchases.Record: after 8,797 earlier disclosures like this, the median 60-session excess return was −3.1%, within 1 percentage point of all comparable disclosures (−3.2%).
- The latest purchase is 2 days old (2026-10-15). The buying is current, not left over from an earlier quarter.
Bear case · discount it
- Company actions4 of 7 purchase lines are subscriptions to newly issued shares (“Teckning”), bought from the company at an issue price and not in the market. Insiders often take part to support a financing.
- Buying at this level is normal here: 5 insiders bought in the previous 180 days and 4 in this one.Record: after 2,869 earlier disclosures like this, the median 60-session excess return was −2.6%, within 1 percentage point of all comparable disclosures (−2.7%).
- Company resultsThe company is loss-making on the latest captured figures: profit margin −185%, return on equity −310%.
- Share price and tradingThe share price is down 66% over six months (three months −59%, one month −8.7%) and stands 74% below its 52-week high. Insiders have bought into a fall the market has not reversed.Record (nearest stored case: price 20% or more below its prior 52-week high): after 11,077 earlier disclosures like this, the median 60-session excess return was −3.2%, within 1 percentage point of all comparable disclosures (−2.6%).
- Share price and tradingOver three months the share price changed −59% and the median of 271 Healthcare companies changed −6.3%: 53 points behind. The market has marked this company down against its own sector.
Evidence still missing
- No buyer here has 5 or more completed earlier purchases on record, so there is no track record to weigh.
- Only one reading of profitability is held (profit margin −185%). Whether earnings and cash flow are rising or falling needs the last two reports side by side.
- The filings give the size of each trade, not what the buyer already held. Whether a purchase added 1% to a personal stake or doubled it is not known.
Checked and under the threshold: 5, 1 close to it
- Bear1 of 4 buyers filed as a person closely associated with a manager. Counted for the bear side from half. close to the threshold
- BullAt most 1 insider bought within any 15 days. Counted for the bull side from 3.
- BearThe largest buyer accounts for 57% of the value bought. Counted for the bear side from 80%.
- BearNo insider sale is recorded in the same 180 days.
- BearThe register of Finansinspektionen shows no published net short position in this company. Positions under 0.5% are never published, so this does not show that nobody is short.
Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.
Signal history
71.3 / 100
Latest recorded score
↑ +8.6 ptsversus the comparable snapshot on 2026-08-27 (52 calendar days apart)
- Recorded snapshots
- 18
- First snapshot
- 2026-08-26
Only scores captured when the scoring run completed are compared. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.
Why did it change?
Decomposition across the five score factors between comparable snapshots; historical scores are not recalculated.
- Purchase size-0.1 pts
- Recency+8.7 pts
Signal score history
Fixed 0–100 scale; dates are spaced by calendar time.
Recent recorded points
- 62.7
- 64.6
- 65.3
- 61.7
- 71.3
View all recorded scores
| Snapshot date | Signal score |
|---|---|
| 2026-08-26 | 62.7 |
| 2026-08-27 | 62.7 |
| 2026-09-30 | 44.3 |
| 2026-10-01 | 65.2 |
| 2026-10-02 | 64.6 |
| 2026-10-03 | 64.6 |
| 2026-10-04 | 64.6 |
| 2026-10-05 | 66.0 |
| 2026-10-06 | 65.3 |
| 2026-10-07 | 64.7 |
| 2026-10-08 | 64.1 |
| 2026-10-09 | 63.5 |
| 2026-10-12 | 62.1 |
| 2026-10-13 | 61.7 |
| 2026-10-14 | 61.3 |
| 2026-10-15 | 72.6 |
| 2026-10-16 | 71.9 |
| 2026-10-18 | 71.3 |
Sector context
- Buying breadth
- 6.1% (48 / 792 issuers)
- Sector rank
- #11 / 12
- 7D breadth change
- -0.4 pp · vs 2026-10-12 (6d)
- 30D breadth change
- History building
This is sector-level research context. It does not affect the Insider Signal or ranking.
Insider profile outcomes
Historical performance following insider filings. The company role is translated below each name while preserving the original title.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = completed events with positive excess return ÷ total completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
- Small-sample rule: n<5 is shown for transparency and is not scored.
Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 6Developing evidence | 100.0% (6/6) | 50.0% (3/6) | -2.3% | +1.3% | -8.5% |
| 20D | 3Small sample | 100.0% (3/3) | 66.7% (2/3) | +24.9% | +14.6% | -6.1% |
| 60D | 3Small sample | 100.0% (3/3) | 100.0% (3/3) | +87.9% | +80.7% | +63.7% |
| 120D | 3Small sample | 100.0% (3/3) | 100.0% (3/3) | +28.8% | +31.1% | +5.3% |
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 4Small sample | 100.0% (4/4) | 75.0% (3/4) | +4.6% | +6.0% | -8.0% |
| 20D | 3Small sample | 100.0% (3/3) | 66.7% (2/3) | +24.9% | +14.6% | -6.1% |
| 60D | 3Small sample | 100.0% (3/3) | 100.0% (3/3) | +87.9% | +80.7% | +63.7% |
| 120D | 3Small sample | 100.0% (3/3) | 100.0% (3/3) | +28.8% | +31.1% | +5.3% |
Market context
PRICE PERFORMANCE
VOLATILITY & LIQUIDITY
- Volatility
- 73.7%
- Beta
- 0.03
- Avg daily volume
- SEK 74,372.4
VALUATION
- Market cap
- SEK 204.7M
- P/E
- —
FUNDAMENTALS
- Profit margin
- -184.8%
- ROE
- -309.8%
- Industry
- Medical Devices
Prices to 18 Oct 2026: OpenBB/yfinance; volume from price cache (yfinance). From OpenBB/yfinance, captured 15 Oct 2026: Market cap, Profit margin, ROE, Beta, Industry. It does not affect the insider score or rank.
Disclosed net short positions
The Finansinspektionen register, read 18 Oct 2026, publishes no net short position of 0.5% or more in this issuer. Positions below 0.5% are never published, so this is not evidence that nobody is short.
Short-position disclosures are external context; they do not affect the insider score, ranking, or filing eligibility.
Insiders' buying price vs the latest close
Insiders paid 15.00 SEK a share on average (7 purchase lines, 4 buyers, 2026-09-29 – 2026-10-15). The close on 2026-10-16 was 5.7% below that price.
The latest purchase (2026-10-15) was at 15.00 SEK; the close was 5.7% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Buying size vs market trading
62.58% · of estimated traded value in the same period
2026-09-21 – 2026-10-16 · 20 recorded trading sessions
- Disclosed qualifying purchases
- 1,750,575 SEK
- Estimated market traded value
- 2,797,452 SEK
Market-data coverage: 505 verified sessions · Latest session: 2026-10-16 · Ratio status: Available
Recent and largest purchase events / preceding 60-session ADTV
- Oct 15 · Robert Molander · Styrelseledamot466,875 SEK · 433.06%107,807 SEK ADTV
- Oct 14 · jesper hoeiland · Styrelseordförande619,995 SEK · 669.96%92,543 SEK ADTV
- Oct 05 · Pia Henriksson Renaudin · Verkställande direktör (VD)21,960 SEK · 23.40%93,848 SEK ADTV
- Sep 30 · Michael Colérus · Ekonomichef/finanschef/finansdirektör123,795 SEK · 139.69%88,623 SEK ADTV
- Sep 29 · Pia Henriksson Renaudin · Verkställande direktör (VD)139,995 SEK · 159.53%87,756 SEK ADTV
- Sep 29 · jesper hoeiland · Styrelseordförande377,955 SEK · 430.69%87,756 SEK ADTV
Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.
Latest news
No news has been captured for this company.
Regulatory filings
The filing records held for this company carry no link to the original notice.
Filing evidence
These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.
Excluded transactions & classification
21 qualifying purchase disclosure(s) · 21 transaction line(s)
Oct 15, 2026Teckning
Robert Molander · Styrelseledamot
BTA (betald tecknad aktie) · 31125.0 shares × 15.0 SEK · —
Oct 14, 2026Teckning
jesper hoeiland · Styrelseordförande
BTA (betald tecknad aktie) · 41333.0 shares × 15.0 SEK · —
Oct 5, 2026Förvärv
Pia Henriksson Renaudin · Verkställande direktör (VD)
BTA (betald tecknad aktie) · 1464.0 shares × 15.0 SEK · —
Unfold all 18 remaining filing row(s)
| Transaction date | Published | Filer | Role | Transaction | Instrument | Price (local currency) | Quote currency | Volume | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 2026-10-01 | Michael Colérus | Ekonomichef/finanschef/finansdirektör | Teckning | BTA (betald tecknad aktie) | 15.0 SEK | SEK | 8253.0 | — |
| 2026-09-29 | 2026-10-01 | jesper hoeiland | Styrelseordförande | Teckning | BTA (betald tecknad aktie) | 15.0 SEK | SEK | 25197.0 | — |
| 2026-09-29 | 2026-09-30 | Pia Henriksson Renaudin | Verkställande direktör (VD) | Förvärv | BTA (betald tecknad aktie) | 15.0 SEK | SEK | 2667.0 | — |
| 2026-09-29 | 2026-09-30 | Pia Henriksson Renaudin | Verkställande direktör (VD) | Förvärv | BTA (betald tecknad aktie) | 15.0 SEK | SEK | 6666.0 | — |
| 2026-02-20 | 2026-02-23 | Robert Molander | Styrelseledamot | Teckning | Aktie | 0.20 SEK | SEK | 5952380.0 | — |
| 2026-02-16 | 2026-02-17 | Pia Henriksson Renaudin | Verkställande direktör (VD) | Teckning | Aktie | 0.2 SEK | SEK | 37500.0 | — |
| 2026-02-16 | 2026-02-17 | Pia Renaudin | Verkställande direktör (VD) | Teckning | Aktie | 0.2 SEK | SEK | 358470.0 | — |
| 2026-02-16 | 2026-02-17 | jesper hoeiland | Styrelseordförande | Teckning | Aktie | 0.2 SEK | SEK | 2976190.0 | — |
| 2026-02-16 | 2026-02-17 | Michael Colérus | Ekonomichef/finanschef/finansdirektör | Teckning | Aktie | 0.2 SEK | SEK | 642608.0 | — |
| 2026-02-03 | 2026-02-04 | jesper hoeiland | Styrelseordförande | Förvärv | Aktie | 0.25 SEK | SEK | 800000.0 | — |
| 2026-01-30 | 2026-02-02 | jesper hoeiland | Styrelseordförande | Förvärv | Aktie | 0.225 SEK | SEK | 44756.0 | — |
| 2026-01-30 | 2026-01-30 | Pia Henriksson Renaudin | Verkställande direktör (VD) | Förvärv | BTA (betald tecknad aktie) | 0.2 SEK | SEK | 1150000.0 | — |
| 2026-01-29 | 2026-02-02 | jesper hoeiland | Styrelseordförande | Förvärv | Aktie | 0.2 SEK | SEK | 55163.0 | — |
| 2026-01-28 | 2026-01-30 | Michael Colérus | Ekonomichef/finanschef/finansdirektör | Förvärv | BTA (betald tecknad aktie) | 0.20 SEK | SEK | 441310.0 | — |
| 2026-01-26 | 2026-01-27 | Pia Henriksson Renaudin | Verkställande direktör (VD) | Förvärv | BTA (betald tecknad aktie) | 0.2 SEK | SEK | 295100.0 | — |
| 2026-01-26 | 2026-01-27 | Pia Renaudin | Verkställande direktör (VD) | Förvärv | BTA (betald tecknad aktie) | 0.2 SEK | SEK | 176355.0 | — |
| 2026-01-26 | 2026-01-27 | Michael Colérus | Ekonomichef/finanschef/finansdirektör | Förvärv | BTA (betald tecknad aktie) | 0.2 SEK | SEK | 558690.0 | — |
| 2026-01-07 | 2026-01-08 | jesper hoeiland | Styrelseordförande | Förvärv | Aktie | 0.26 SEK | SEK | 957823.0 | — |
Showing 21 of 21 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Other disclosed transactions · excluded from score
View 4 other transaction(s)
Dec 5, 2025Avyttring
Pia Henriksson Renaudin · Verkställande direktör (VD)
Teckningsoption · 716940.0 shares × 0.1 SEK · —
Dec 5, 2025Avyttring
jesper hoeiland · Styrelseordförande
Warrant · 5952380.0 shares × 0.10 SEK · —
Dec 5, 2025Avyttring
Robert Molander · Styrelseledamot
Teckningsoption · 11904760.0 shares × 0.10 SEK · —
Unfold all 1 remaining filing row(s)
| Transaction date | Published | Filer | Role | Transaction | Instrument | Price (local currency) | Quote currency | Volume | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-05 | 2025-12-05 | Michael Colérus | Ekonomichef/finanschef/finansdirektör | Avyttring | Teckningsoption | 0.1 SEK | SEK | 1285715.0 | — |
Showing 4 of 4 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Snapshot & identity
- Snapshot date
- 2026-10-18
- Ticker
- SCIB.ST
- ISIN
- SE0030285706
- Sector
- Healthcare
- Industry
- Medical Devices
Company logos by Parqet